Cost effectiveness of budesonide/formoterol vs fluticasone/salmeterol: Real-world effectiveness and safety in COPD

被引：0
|
作者：
Hedegaard, Morten [1 ]
Janson, Christer [2 ]
Lisspers, Karin [3 ]
Stallberg, Bjorn [3 ]
Johansson, Gunnar [3 ]
Jorgensen, Leif [1 ]
Larssen, Kjell [4 ]
机构：
[1] Astrazeneca, R&D, Sodertalje, Sweden
[2] Uppsala Univ, Dept Med Sci, Resp Med, Uppsala, Sweden
[3] Uppsala Univ, Dept Publ Hlth & Caring Serv Family Med & Prevent, Uppsala, Sweden
[4] Karolinska Inst, Natl Inst Environm Med, Unit Lung & Allergy Res, Stockholm, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2013年 / 42卷
关键词：
COPD; -; management; Exacerbation; Pneumonia;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
1999
引用
收藏
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF BUDESONIDE/FORMOTEROL VERSUS FLUTICASONE/SALMETEROL BASED ON REAL-WORLD EFFECTIVENESS IN PATIENTS WITH COPD
    Hedegaard, M.
    Janson, C.
    Lisspers, K.
    Stallberg, B.
    Johansson, G.
    Jorgensen, L.
    Larsson, K.
    VALUE IN HEALTH, 2012, 15 (07) : A563 - A563
  • [2] COST EFFECTIVENESS OF BUDESONIDE/FORMOTEROL VERSUS FLUTICASONE/SALMETEROL FROM A SWEDISH HEALTH CARE PERSPECTIVE BASED ON REAL-WORLD EFFECTIVENESS AND SAFETY IN PATIENTS WITH COPD
    Hedegaard, M.
    Janson, C.
    Lisspers, K.
    Stallberg, B.
    Johansson, G.
    Jorgensen, L.
    Larsson, K.
    VALUE IN HEALTH, 2013, 16 (03) : A235 - A235
  • [3] Budesonide/formoterol versus salmeterol/fluticasone for asthma in children: an effectiveness and safety analysis
    Jiang, Ping
    Zhao, Lanyu
    Yao, Zezhong
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (17) : 1283 - 1289
  • [4] COST ANALYSIS EFFECTIVENESS OF USE OF BUDESONIDE / FORMOTEROL FOR SALMETEROL / FLUTICASONE, IN PATIENTS WITH MODERATE AND SEVERE ASTHMA IN COLOMBIA
    Romero Prada, M. E.
    Roa Cardenas, N. C.
    Huerfano, L.
    VALUE IN HEALTH, 2017, 20 (09) : A889 - A889
  • [5] Comparative analysis of budesonide/formoterol and fluticasone/salmeterol combinations in COPD patients: findings from a real-world analysis in an Italian setting
    Perrone, Valentina
    Sangiorgi, Diego
    Buda, Stefano
    Esposti, Luca Degli
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 2749 - 2755
  • [6] Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety
    Suissa, Samy
    Dell'Aniello, Sophie
    Ernst, Pierre
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2022, 19 (01) : 109 - 117
  • [7] Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy
    Cossette, Benoit
    Beauchesne, Marie-France
    Forget, Amelie
    Lemiere, Catherine
    Larivee, Pierre
    Rey, Evelyne
    Blais, Lucie
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 112 (05) : 459 - 464
  • [8] Cost Effectiveness of Budesonide/Formoterol for Maintenance and Reliever Therapy versus Salmeterol/ Fluticasone plus Salbutamol in the Treatment of Asthma
    Gunnar Johansson
    Emma B. Andreasson
    Per E. Larsson
    Claus F. Vogelmeier
    PharmacoEconomics, 2006, 24 : 695 - 708
  • [9] Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma
    Johansson, Gunnar
    Andreasson, Emma B.
    Larsson, Per E.
    Vogelmeier, Claus F.
    PHARMACOECONOMICS, 2006, 24 (07) : 695 - 708
  • [10] Cost-Effectiveness of Salmeterol, Fluticasone, and Combination Therapy for COPD
    Oba, Yuji
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (04): : 226 - 232
12345